WILLIS LEASE FINANCE CORP

WLFC
About the company

Willis Lease Finance Corporation, together with its subsidiaries, operates as a lessor and servicer of commercial aircraft and aircraft engines worldwide. It operates in two segments, Leasing and Related Operations, and Spare Parts Sales. The company engages in acquiring and leasing commercial aircraft, aircraft engines, and related aircraft equipment, as well as the purchase and resale of commercial aircraft engines and other aircraft equipment, and service and maintenance related businesses.

Country: United StatesPrice: $46.04Market Cap: $1.1B

Investment snapshot

41%positive consensus
Scored 1d ago

Positive

7

BUY / PASS

Neutral / negative

5 / 4

NEUTRAL / FAIL

Median fair value

$184.80

+301.4% vs price

Models with upside

11 / 17

Positive margin of safety

Strongest signal

WLFC undervalued: all 11 models price fair value above $46.04 (median $184.80)

Key risk

Split decision: 6 PASS · 5 NEUTRAL · 4 FAIL · 1 BUY

Framework analysis

VerdictMeaning
BUYPositive purchase signal: the framework's buy requirements are met.
PASSThe company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state.
NEUTRALNeither a positive nor negative conclusion. It does not mean to hold an existing position.
FAILThe company does not clear the framework's requirements.
RankedRanked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL.

Current investor scores use trailing 12-month flows and the latest balance sheet where supported. Multi-year and EPS tests retain annual history; each framework shows its financial basis below. Intrinsic values use annual financials.

MetricGraham

Defensive Value

Buffett

Quality Compounder

Lynch

GARP

Greenblatt

Magic Formula

Piotroski

F-Score

Dreman

Contrarian Value

Munger

Quality Focus

Pabrai

Dhandho Framework

Akre

Three-Legged Stool

Marks

Risk-Aware Value

Ackman

Activist Value

Templeton

Global Bargain Hunter

Sleep

Scale Economies Shared

Asness

Systematic Factors

Neff

Low-P/E Total Return

Schloss

Asset-Value Discipline

O'Shaughnessy

Systematic Factor Composite

VerdictPASSFAILFAILNot rankedPASSPASSPASSNEUTRALFAILBUYNEUTRALNEUTRALPASSNEUTRALPASSNEUTRALFAIL
Score
AnalysisChecking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…
Intrinsic Value (annual)N/AN/AN/AN/AN/AN/A
Margin of Safety+75.0%+86.4%+88.0%+62.1%N/A+75.1%+93.2%+90.8%+55.0%+54.3%+96.5%+36.9%N/AN/AN/AN/AN/A
Financial Basis

Annual history · FY 2025

Latest source filing: 2026-03-30

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-03-30

Score computed: 2026-11-14

Annual history · FY 2025 · Balance sheet at 2026-09-30

Latest source filing: 2026-11-03

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-03-30

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-03-30

Score computed: 2026-11-14

Annual history · FY 2025 · Balance sheet at 2026-09-30 · Market data at 2026-11-01

Latest source filing: 2026-11-03

Score computed: 2026-11-14

Qualitative assessment · Annual history · FY 2025 · Balance sheet at 2026-09-30

Latest source filing: 2026-11-03

Score computed: 2026-11-14

Qualitative assessment · Annual history · FY 2025

Latest source filing: 2026-03-30

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment · Balance sheet at 2026-09-30

Latest source filing: 2026-11-03

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment

Latest source filing: 2026-03-30

Score computed: 2026-11-14

Annual history · FY 2025 · Balance sheet at 2026-09-30 · Market data at 2026-11-01

Latest source filing: 2026-11-03

Score computed: 2026-11-14

Annual history · FY 2025 · Price history 2025-01-01–2026-11-01 · Balance sheet at 2026-09-30

Latest source filing: 2026-11-03

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment

Latest source filing: 2026-03-30

Score computed: 2026-11-14

Annual history · FY 2025 · Balance sheet at 2026-09-30 · Price history 2025-01-01–2026-11-01

Latest source filing: 2026-11-03

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-03-30

Score computed: 2026-11-14

Annual history · FY 2025 · Balance sheet at 2026-09-30

Latest source filing: 2026-11-03

Score computed: 2026-11-14

Annual history · FY 2025 · Price history 2025-01-01–2026-11-01

Latest source filing: 2026-03-30

Score computed: 2026-11-14

Where It Passes

  • Valuation models100% pass✓ 11▾

    WLFC undervalued: all 11 models price fair value above $46.04 (median $184.80)

    Graham fair value$183.81
    ✓Graham+75.0% margin vs $46.04
    Buffett fair value$338.22
    ✓Buffett+86.4% margin vs $46.04
    Lynch fair value$384.75
    ✓Lynch+88.0% margin vs $46.04
    Greenblatt fair value$121.42
    ✓Greenblatt+62.1% margin vs $46.04
    Dreman fair value$184.80
    ✓Dreman+75.1% margin vs $46.04
    Munger fair value$676.88
    ✓Munger+93.2% margin vs $46.04
    Pabrai fair value$502.40
    ✓Pabrai+90.8% margin vs $46.04
    Akre fair value$102.40
    ✓Akre+55.0% margin vs $46.04
    Marks fair value$100.77
    ✓Marks+54.3% margin vs $46.04
    Ackman fair value$1331.08
    ✓Ackman+96.5% margin vs $46.04
    Templeton fair value$72.96
    ✓Templeton+36.9% margin vs $46.04
  • Cash Flow90% pass✓ 11✗ 1▾

    9 of 10 pass — Lynch objects

    Free Cash Flow Proxy$194.2M
    ✓BuffettPositive and growing
    FCF Positive and Growing$252.2M
    ✗LynchPositive and growing
    Operating Cash Flow$283.2M
    ✓PiotroskiCFO > 0
    (CFO / Total Assets) vs ROACFO/Assets=7.20%, ROA=2.89%
    ✓PiotroskiCFO/Assets > ROA
    Price / (CFO / Shares)1.1x
    ✓Dreman< 8x
    P/E or FCF YieldP/E=3.0x, FCF Yield=24.0%
    ✓PabraiP/E < 15 or FCF Yield > 10%
    FCF Positive17/17 years FCF positive
    ✓MarksPositive FCF in majority of recent years
    (OCF - CapEx) / Market Cap80.7%
    ✓Ackman>= 4%
    Price / FCF per Share1.2x
    ✓Ackman<= 25
    Positive Operating Cash Flow frequency26/26 years positive
    ✓SleepPositive OCF in >= 70% of available years
    Operating Cash Flow - Capital Expenditures$252.2M
    ✓Neff> $0 (app proxy for a strong fundamental case)
    (Operating cash flow - capex) / market capitalization+24.01%; #237/4519 (top 5.2%)
    ✓OshaughnessyTop 10% of eligible cross-section
  • Valuation77% pass✓ 23✗ 5▾

    10 of 13 pass — Greenblatt, Asness and Oshaughnessy object

    Price / 3-yr avg EPS3.7x
    ✓Graham<= 15x
    Price-to-Book Ratio0.5x
    ✓Graham<= 1.5x
    P/E x P/B1.80
    ✓Graham<= 22.5
    Basic earnings-growth PEG (dividends excluded)0.04
    ✓Lynch< 1.0 (ideally < 0.5)
    EBIT / Enterprise Value2.8%
    ✗Greenblatt> 10%
    Earnings Yield + ROC AssessmentEY=2.8%, ROC=None
    ✗GreenblattBoth EY > 10% and ROC > 25%
    Price / EPS3.0x
    ✓Dreman< 12x✓Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)
    Price / (CFO / Shares)1.1x
    ✓Dreman< 8x
    Price / Book Value per Share0.5x
    ✓Dreman< 1.2x✓Templeton< 1.5x✓SchlossP/B <= 0.80x (app cutoff)
    Valuation ReasonablenessP/E=3.0x, OE Yield=62.2%
    ✓MungerP/E < 25 or Owner Earnings Yield > 5%
    P/E or FCF YieldP/E=3.0x, FCF Yield=24.0%
    ✓PabraiP/E < 15 or FCF Yield > 10%
    P/B or P/E vs. Historical AverageP/E=3.0x, P/B=0.5x
    ✓MarksP/E < 15 or P/B < 2.0
    Discount to Intrinsic Value75.1% (IV=$184.80 vs Price=$46.04)
    ✓Marks>= 20% below intrinsic value
    Price / FCF per Share1.2x
    ✓Ackman<= 25
    Price vs. Trailing Low119% of trailing low ($38.70)
    ✓Templeton<= 120% of trailing low (certified split-adjusted live window)
    Net income / market capitalization+10.83%; #581/6340 (top 9.2%)
    ✓AsnessTop 30% of eligible cross-section✓OshaughnessyTop 10% of eligible cross-section
    Positive book equity / market capitalization+0.6945; #2221/6449 (top 34.4%)
    ✗AsnessTop 30% of eligible cross-section
    Price / Diluted EPS3.0x
    ✓NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)
    (EPS CAGR % + Dividend Yield %) / P/E24.69
    ✓Neff> 0.7 (Neff's published traditional edge)
    Price / Tangible Book Value per Share0.47x
    ✓SchlossP/TBV <= 1.00x (app cutoff)
    Book Value per Share Change+60.8%
    ✓SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)
    Revenue / market capitalization+0.6953; #2208/5247 (top 42.1%)
    ✗OshaughnessyTop 10% of eligible cross-section
    (Operating cash flow - capex) / market capitalization+24.01%; #237/4519 (top 5.2%)
    ✓OshaughnessyTop 10% of eligible cross-section
    Trailing six-month price return through the evaluation date-31.95%; #4500/6202 (top 72.6%)
    ✗OshaughnessyTop 10% of eligible cross-section
  • Verdicts64% pass✓ 7✗ 4▾

    Split decision: 6 PASS · 5 NEUTRAL · 4 FAIL · 1 BUY

    Overall verdict
    ✓GrahamPASS (4/9)✗BuffettFAIL (2/9)✗LynchFAIL (4/7)•GreenblattNot ranked✓PiotroskiPASS (F-Score 5)✓DremanPASS (6/11)✓MungerPASS (2/4)•PabraiNEUTRAL (2/3)✗AkreFAIL (1/6)✓MarksBUY (4/5)•AckmanNEUTRAL (6/9)•TempletonNEUTRAL (5/8)✓SleepPASS (3/6)•AsnessNEUTRAL (Not ranked)✓NeffPASS (5/6)•SchlossNEUTRAL (4/7)✗OshaughnessyFAIL (Rank #829/963 (Top 86.1%))

Where It Falls Short

  • Efficiency0% pass✓ 1✗ 10▾

    No clean pass — all 8 investors flag at least one efficiency criterion

    Current Ratio
    ✗Graham>= 2.0
    ROIC (3-5 yr avg)1.9%
    ✗Buffett> 10%
    ROIC - WACC-8.1%
    ✗BuffettPositive (WACC = 10%)
    EBIT / (NWC + Net Fixed Assets)
    ✗Greenblatt> 25%
    Current Ratio Change YoY
    ✗PiotroskiIncreased YoY
    Revenue / Total Assets Change YoY0.17x -> 0.19x
    ✓PiotroskiImproved YoY
    Current Assets / Current Liabilities
    ✗Dreman> 1.5
    Return on Invested Capital2.5%
    ✗Munger> 15%
    ROIC (high and growing)FY2023: ROIC=2.3%; FY2024: ROIC=4.1%; FY2025: ROIC=2.5%
    ✗AkreLatest 3 consecutive FYs: ROIC > 15% in each
    Reinvestment Rate x ROIC2.3% (RR=92% x ROIC=2.5%)
    ✗AkreReinvestment Rate * ROIC > 10%
    ROIC (5-year)0/5 years above 12% (latest 2.5%)
    ✗SleepROIC > 12% in a majority of years
  • Debt & Leverage8% pass✓ 1✗ 14▾

    11 of 12 flag WLFC's debt & leverage — Graham, Buffett, Lynch +8 more

    LT Debt vs Net Current Assets
    ✗GrahamLT Debt <= Net Current Assets
    Debt/Equity & Interest CoverageD/E: 4.08, IC: 0.8x
    ✗BuffettD/E < 0.5 AND Interest Coverage > 5x
    Total Debt / Equity3.46
    ✗Lynch< 0.33
    Cash - Long-term Debt$-2.5B
    ✗LynchPositive preferred
    LT Debt / Total Assets Change68.68% -> 68.60%
    ✓PiotroskiDecreased YoY
    Current Assets / Current Liabilities
    ✗Dreman> 1.5✗SchlossCurrent ratio >= 1.50x (app cutoff)
    Total Debt / Shareholders' Equity3.46
    ✗Dreman< 0.8✗Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✗SchlossD/E < 1.00x
    Debt Levels3.46
    ✗MungerDebt/Equity < 0.5✗AkreDebt/Equity < 0.3
    Interest Coverage & Debt/EBITDAIC=0.8x, D/EBITDA=12.5x
    ✗MarksInterest Coverage > 3x; Debt/EBITDA < 4x
    Total Debt / Shareholders Equity3.46
    ✗Ackman<= 1.0
    Negative debt-to-equity (higher means less debt)-3.4609; #3980/4210 (top 94.5%)
    ✗AsnessTop 30% of eligible cross-section
  • Profitability38% pass✓ 19✗ 16▾

    10 of 16 flag WLFC's profitability — Graham, Buffett, Greenblatt +7 more

    Positive EPS (10 years)24/29 years positive
    ✗GrahamPositive EPS every year for 10 years
    EPS Growth (3-yr avg, 10-yr window)
    ✗Graham>= 33% growth
    Net Income Positive (10+ years)28/29 years positive
    ✗BuffettPositive every year for 10+ years
    ROE (up to 5-year arithmetic mean)9.8%
    ✗Buffett> 15% arithmetic mean (app rule)
    Operating Margin (10-yr trend)14.3% (latest)
    ✓BuffettStable or rising over 10 years
    Free Cash Flow Proxy$194.2M
    ✓BuffettPositive and growing
    Earnings Variance (10-yr CoV)
    ✗BuffettCoV < 0.3
    Retained Earnings Effectiveness
    ✗Buffett$1 retained -> > $1 market value created
    Basic earnings-growth PEG (dividends excluded)0.04
    ✓Lynch< 1.0 (ideally < 0.5)
    3-5 Year EPS CAGR71.1%
    ✓Lynch15-30% (Fast Grower); > 0% to pass
    ROE17.2%
    ✓Lynch> 15%
    EBIT / Enterprise Value2.8%
    ✗Greenblatt> 10%
    Earnings Yield + ROC AssessmentEY=2.8%, ROC=None
    ✗GreenblattBoth EY > 10% and ROC > 25%
    Net Income / Total Assets2.89%
    ✓PiotroskiROA > 0
    ROA Change YoY3.29% -> 2.89% (delta: -0.40%)
    ✗PiotroskiCurrent ROA > Prior ROA
    (CFO / Total Assets) vs ROACFO/Assets=7.20%, ROA=2.89%
    ✓PiotroskiCFO/Assets > ROA
    Gross Margin Change YoY
    ✗PiotroskiImproved YoY
    Pre-Tax Income / Revenue22.0%
    ✓Dreman>= 8%
    Net Income / Shareholders' Equity17.2%
    ✓Dreman> 12%
    Margin of SafetyP/E=3.0x, P/B=0.5x
    ✓PabraiP/B < 1.5 or P/E < 15
    Return on Equity15.6% (3-yr avg)
    ✗AkreROE > 20% (3-year avg)
    Discount to Intrinsic Value75.1% (IV=$184.80 vs Price=$46.04)
    ✓Marks>= 20% below intrinsic value
    Positive Net Income Frequency28/28 years positive
    ✓MarksPositive net income in >= 7 of last 10 years
    Operating Income / Revenue14.3%
    ✗Ackman>= 15%
    Net Income / Shareholders Equity17.2%
    ✓Ackman>= 15%
    5-Year EPS CAGR71.1% CAGR over 5 years
    ✓Templeton> 0% (5-year EPS CAGR)
    Operating Margin Trend15.3% (2023) -> 14.3% (2025)
    ✗TempletonNon-negative operating-margin trend over 3 years
    Revenue growth vs. gross and operating margin trendrevenue up, operating margin 15.3% -> 14.3%
    ✗SleepRevenue rising; gross margin flat or falling; operating margin holding
    Net income / market capitalization+10.83%; #581/6340 (top 9.2%)
    ✓AsnessTop 30% of eligible cross-section✓OshaughnessyTop 10% of eligible cross-section
    Gross profit / total assets
    ✗AsnessTop 30% of eligible cross-section
    Net income / positive book equity+17.18%; #976/5226 (top 18.7%)
    ✓AsnessTop 30% of eligible cross-section
    Negative 5-year standard deviation of ROA-0.0131; #1022/5884 (top 17.4%)
    ✓AsnessTop 30% of eligible cross-section
    3-5 Year Diluted EPS CAGR71.1% over 5 years
    ✗Neff7%-20% annualized
    Positive Diluted-EPS Years9/10 years positive
    ✓Schloss>= 70% positive over 5-10 observed years (app rule)
  • Growth50% pass✓ 8✗ 5▾

    4 of 8 pass — Graham, Dreman, Sleep +1 more object

    EPS Growth (3-yr avg, 10-yr window)
    ✗Graham>= 33% growth
    Basic earnings-growth PEG (dividends excluded)0.04
    ✓Lynch< 1.0 (ideally < 0.5)
    3-5 Year EPS CAGR71.1%
    ✓Lynch15-30% (Fast Grower); > 0% to pass
    Inventory Growth vs Revenue GrowthN/A (no inventory)
    ✓LynchInventory growth < Revenue growth
    EPS Growth Direction
    ✗DremanPositive over recent years
    EPS CAGR
    ✗Dreman> 5% annualized
    Positive Net Income Frequency28/28 years positive
    ✓MarksPositive net income in >= 7 of last 10 years
    3yr Median Revenue Growth34.2%
    ✓Ackman>= 5%
    Positive EPS Growth Frequency4/5 years with positive EPS growth
    ✓AckmanPositive EPS growth in >= 3 of last 5 years
    5-Year EPS CAGR71.1% CAGR over 5 years
    ✓Templeton> 0% (5-year EPS CAGR)
    Revenue growth vs. gross and operating margin trendrevenue up, operating margin 15.3% -> 14.3%
    ✗SleepRevenue rising; gross margin flat or falling; operating margin holding
    5-year Revenue CAGR20.4%
    ✓SleepCAGR > 7%
    3-5 Year Diluted EPS CAGR71.1% over 5 years
    ✗Neff7%-20% annualized

Business & financials

Financial snapshot: annual FY 2025. Current investor scores may use newer quarterly data.

Company Profile

Industry: Wholesale
SIC Sector: Durable Goods Wholesale
Size: Small Cap($1.1B)
Revenue: $730.2M+28.3% YoY
Net Income: $113.8M+4.7% YoY

Financial Snapshot

Operating Margin14.3%
Return on Equity17.2%
Debt / Equity4.08
Current Ratio--
EPS (Diluted)$15.39+0.3% 1y
Buybacks (1y)$3.8M
Buybacks (2y)$3.8M
Shares Retired−2.7% / −6.1% 2y

Shareholder Return

Fiscal 2025

Issued 2.7% of shares last year, 6.1% issued over two.

Buybacks
$3.8M
Dividends
$8.7M

What drove EPS

A buyback raises earnings per share without the company earning more. This splits each year's change into the two.

FY23
1787.9% = 704.9% + 134.5%
FY24
146.2% = 148.1% + −0.7%
FY25
0.3% = 4.7% + −4.2%
Earnings Fewer shares More shares

The two parts do not sum exactly to the total — the difference is the cross-term, plus preferred capital where the company has any. It is left visible rather than distributed into the other two.

Share count is the denominator the filer used for diluted EPS, recovered as net income ÷ EPS — not the balance-sheet count, which is a point-in-time figure and would put the timing difference into this split. Years with a loss are omitted: a smaller share count makes a loss per share larger, so the decomposition inverts.

Company Financials

Latest TTM and quarters alongside annual years

TTM sums four consecutive quarters and uses the latest quarter-end balances. Quarter columns show three-month results; annual columns show full-year totals. Growth compares the same period a year earlier. EPS is not added for TTM; full-year ratios are blank for quarters.

The latest annual period end is unavailable. Showing the latest fiscal cycle’s quarters; quarter and annual columns may overlap. Quarterly shows the full quarter history.

MetricTTM · 2025-09-30

2024-10-01 – 2025-09-30

Sources · derived quarter values

Derived from cumulative filings: revenue, net income, operating income, ebit, pre tax income, interest expense, operating cash flow, depreciation amortization, capex, dividends paid.

Q3 FY 2026

2026-07-01 – 2026-09-30

Sources · derived quarter values

Derived from cumulative filings: operating cash flow, capex, dividends paid.

Q2 FY 2026

2026-04-01 – 2026-06-30

Sources · derived quarter values

Derived from cumulative filings: operating cash flow, capex, dividends paid.

Q1 FY 2026

2026-01-01 – 2026-03-31

Sources
FY 2025
Sources
  • 10-K/A · 2026-03-30
FY 2024
Sources
  • 10-K · 2025-03-11
FY 2023
Sources
  • 10-K · 2024-03-15
FY 2022
Sources
  • 10-K · 2023-03-10
FY 2021
Sources
  • 10-K · 2022-03-14
Market Cap$1.1Bcurrent------$1.2Best.$1.3Best.$304.3Mest.$345.0Mest.$206.3Mest.
Revenue$689.4M$246.3M↑34%$194.0M↓1%$194.3M↑23%$730.2M↑28%$569.2M↑36%$418.6M↑34%$311.9M↑14%$274.2M
Operating Income$119.6M$11.5M↓70%$34.0M↑20%$33.8M↑41%$104.3M↓28%$144.4M↑125%$64.2M↑552%$9.9M↑18%$8.3M
Net Income$122.6M$11.7M↓52%$30.2M↓50%$25.1M↑49%$113.8M↑5%$108.6M↑148%$43.8M↑705%$5.4M↑62%$3.4M
EPS (Diluted)--$0.47↓86%$1.31↓84%$3.26↑48%$15.39$15.34↑146%$6.23↑1788%$0.33$0.00
Gross Margin—————————
Operating Margin17.3%4.7%↓78%17.5%↑21%17.4%↑15%14.3%↓44%25.4%↑65%15.3%↑386%3.2%↑4%3.0%
ROE18.9%———17.2%↓13%19.8%↑98%10.0%↑642%1.3%↑51%0.9%
Total Debt$2.2B$2.5B↑13%$2.3B↓17%$2.3B↑1%$2.7B↑19%$2.3B↑26%$1.8B↓2%$1.8B↑3%$1.8B
Shareholders' Equity$650.2M$729.5M↑12%$708.6M↑15%$694.4M↑23%$662.1M↑21%$549.3M↑25%$439.0M↑8%$404.7M↑8%$375.9M
Current Ratio—————————
Debt / Equity3.443.463.28↓28%3.25↓18%4.08↓1%4.124.11↓10%4.56↓4%4.76
Operating Cash Flow$277.0M$104.8M↑64%$77.5M↓26%$56.7M↑38%$283.2M$284.4M↑24%$229.7M↑59%$144.4M↑59%$90.7M
Free Cash Flow$241.0M$102.7M↑78%$74.8M↓21%$53.1M↑58%$252.2M↓6%$268.8M↑20%$224.6M↑63%$137.8M↑56%$88.5M

Score history

Historical Score Timeline

Industry peers

Industry Peers

Similar companies in Wholesale

WLFC vs Peers — Financial Grading

Revenue$730.2MBottom 25%
Net Income$113.8MBottom 25%
ROE17.2%Median
D/E4.08Bottom 25%
Op. Margin14.3%Top 25%
Curr. Ratio—
CompanyMarket CapPriceRevenueNet IncomeROED/EOp. MarginCurr. RatioGrahamBuffettLynchGreenblattPiotroskiDreman
MCKESSON CORPMCK$127.3B$1102.81$403.4B$4.8B-219.2%-3.001.5%0.852/95/94/70/3F-Score 61/11
W.W. GRAINGER, INC.GWW$69.7B$1489.30$17.9B$1.7B45.7%0.6713.9%2.834/96/94/71/3F-Score 65/11
CARDINAL HEALTH INCCAH$65.0B$281.10$254.2B$1.7B-59.5%-3.081.0%0.882/93/93/70/3F-Score 81/11
SYSCO CORPSYY$38.0B$77.10$81.4B$1.8B99.9%—3.8%1.213/95/95/71/3F-Score 42/11
RELIANCE, INC.RS$21.8B$427.33$14.3B$739.4M10.3%0.207.1%4.884/97/93/70/3F-Score 55/11
WATSCO INCWSO$12.8B$308.46$7.2B$497.0M17.9%0.1710.0%4.125/97/94/71/3F-Score 68/11
APPLIED INDUSTRIAL TECHNOLOGIES INCAIT$10.9B$297.60$4.6B$393.0M21.3%0.3110.9%3.326/95/94/71/3F-Score 57/11
POOL CORPPOOL$7.7B$216.20$5.3B$406.4M34.3%1.0111.0%2.243/96/94/71/3F-Score 56/11